Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
On top of today’s Alnylam news, we have Congress gearing up to vote on Medicare coverage for multi-cancer screenings and obesity drug coverage. Also, updates on Vertex’s type 1 diabetes cell therapy, and a push for phage therapy.